SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors gear up for the upcoming 10-K filing and earnings report, with the community actively debating the company's turnaround progress and heavy short interest. While some traders are focused on potential squeeze catalysts and debt reduction initiatives, others are closely monitoring for signs of institutional re-entry following recent compliance milestones.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors rally around the company's compelling clinical data and growing buyout speculation, with community members closely tracking potential M&A activity and upcoming Phase 3 trial results. Discussion is heavily focused on the competitive advantage of its sonelokimab therapy, with holders debating the impact of ongoing institutional accumulation against persistent short-selling pressure.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors digest a key leadership change in R&D, with the community actively debating whether the move signals an impending M&A deal or further instability under current management. Sentiment remains polarized, as many shareholders express frustration over stagnant price action while others point to institutional accumulation and potential partnership catalysts as reasons to remain bullish.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant volatility as investors debate the impact of Google's TurboQuant technology on long-term memory demand. While some community members fear a structural decline for the semiconductor sector, others view the sharp pullback as an accumulation opportunity, emphasizing that memory remains a critical component for AI infrastructure.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is surging following a strong quarterly earnings report and optimistic forward guidance that highlights sustained demand for AI-driven data center infrastructure. Investors are actively discussing the stock's role as a potential beneficiary of long-term AI hardware spending, though some community members remain cautious, debating whether current price levels reflect over-optimism or a sustainable upward trend.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is surging following the FDA approval of EMPAVELI for rare kidney diseases, a long-awaited catalyst that has fueled optimism among long-term investors. Community discussion is heavily focused on the potential for a short squeeze given high short interest, while traders closely monitor whether this milestone will finally unlock the stock's long-term M&A and valuation potential.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The biotech sector, represented by the XBI, is currently driven by a surge in M&A activity, highlighted by major deals like the Biogen-Apellis acquisition and Gilead's recent moves. Investors are actively discussing the potential for continued consolidation and sector-wide growth, while community sentiment remains divided between excitement over clinical breakthroughs and cautious concern regarding geopolitical volatility and regulatory challenges.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is experiencing a significant surge in community engagement and institutional activity driven by the expansion of its fully driverless robotaxi services in the Middle East and Southeast Asia in partnership with Uber and Grab. Investors are closely monitoring its increasing robotaxi fleet size and cost-efficiency gains from its Genesis simulation platform, while actively debating the stock's valuation gap compared to sector peers as it prepares for upcoming quarterly financial disclosures.

Mask Network is the core product of Dimension, which is positioned to become the bridge that connects internet users from Web 2.0 to Web 3.0. The foundational technology of Mask Network is a peer-to-peer encrypted messaging application, with new functions continuously being created around this foundation. We at Mask Network are strong believers in the ownership economy. People should own what they produce, people should own their data, their attention and the virtual space they choose to contribute to.  Mask Network integrates decentralized social messaging, borderless payment network, and decentralized file storage and sharing to provide a safe and convenient portal for users to jump right into the continent of decentralized finance and then the new world of Web 3.0.

Mask Network

Mask Network (MASK) is actively trending as traders closely monitor its price action and look for technical setups, with many in the community debating potential breakout levels while comparing it to other small-cap runners. The conversation is heavily focused on potential volatility and short-term momentum, with participants sharing strategies for entry points and scaling out of positions amidst ongoing market uncertainty.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

Market sentiment remains highly volatile as traders debate whether current gains are driven by end-of-quarter window dressing and tactical optimism regarding potential de-escalation in the Middle East or if these moves are simply another bear trap. Community discussion is dominated by skepticism toward official announcements and high-level rhetoric, with many actively loading up on puts to hedge against what they perceive as an ongoing, unstable conflict.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Microbot Medical (NASDAQ:MBOT) Announces Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Microbot Medical (NASDAQ:MBOT - Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported ($0.04) EPS for the quarter, topping analysts' consensus...

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value PR Newswire VANCOUVER, BC, March 27, 2026 Issued on behalf of...

Microbot Medical Inc. $MBOT Shares Purchased by CIBC Private Wealth Group LLC

CIBC Private Wealth Group LLC raised its position in Microbot Medical Inc. (NASDAQ:MBOT - Free Report) by 137.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,454,000 shares of the biotechnology company's stock aft...

Heights Capital Management Inc. Buys New Stake in Microbot Medical Inc. $MBOT

Heights Capital Management Inc. bought a new stake in shares of Microbot Medical Inc. (NASDAQ:MBOT - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with...

Microbot Medical (NASDAQ:MBOT) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened

Microbot Medical (NASDAQ:MBOT) Shares Cross Above Two Hundred Day Moving Average - Here's Why...

Microbot Medical (MBOT) to Release Earnings on Tuesday

Microbot Medical (NASDAQ:MBOT) will be releasing earnings before the market opens on Tuesday, March 24. (View Earnings Report at...

<ul class="summary-bullets"><li>While Microbot's corporate headquarters are in the U.S., the heart of its technical development is its facility in the Caesarea Business and Industrial Park in Israel.</li><li>The company said it maintains sufficient Liberty system inventory in the U.S. to support current customers and is building additional stock to meet anticipated demand.</li></ul>Israel-founded Microbot Medical Inc. (MBOT) said on Tuesday that it is not experiencing any business disruption due to geopolitical events but is actively building additional stock in the U.S. to meet anticipated demand for its Liberty system.Shares of the company, however, traded 3% lower at the time of writing.<h2 class="st-heading-2">Microbot’s Assurance</h2>Microbot <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/03/03/3248415/0/en/Microbot-Medical-Confirms-Continued-Operational-and-Commercial-Stability-Amid-Current-Geopolitical-Event.html">said</a> that it is not experiencing any disruption in either the U.S. or Israel with all personnel continuing to operate as usual and both internal operations and the lead manufacturing partner remaining fully functional.The FDA approved Microbot’s Liberty Endovascular Robotic System, a single-use, remotely operated robotic system for peripheral endovascular procedures, in September 2025. The company said that its commercial focus is now on the U.S. Market which is managed by its U.S.-based commercial team in Hingham.“This ensures uninterrupted service, reliable distribution, and continued advancement of the limited market release of the LIBERTY System as planned,” the company said. It added that the company maintains sufficient inventory in the U.S. to support current customers and is building additional stock to meet anticipated demand. The additional stock is being built through the company's U.S.-based third party logistics partner, it said.“The Company is closely monitoring the situation in the Middle East to ensure the ongoing well-being of its employees and to ensure uninterrupted support for customers, reinforcing its commitment to operational excellence,” it added.While Microbot's corporate headquarters are in the U.S., the heart of its technical development is its facility in the Caesarea Business and Industrial Park in Israel.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, the retail sentiment around MBOT stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.<a href="https://stocktwits.com/symbol/MBOT">MBOT stock</a> has risen 76% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/mdb-stock-sees-biggest-single-day-decline-on-record-wall-street-cuts-price-targets-on-slower-atlas-growth-and-cautious-outlook/cZdekxtRIPK">MDB Stock Sees Biggest Single-Day Decline On Record: Wall Street Cuts Price Targets On Slower Atlas Growth And Cautious Outlook</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company

Microbot said on Tuesday that it is not experiencing any disruption in either the U.S. or Israel with all personnel continuing to operate as usual. 

Equity

Microbot said on Tuesday that it is not experiencing any disruption in either the U.S. or Israel with all personnel continuing to operate as usual. 


Microbot Medical (NASDAQ:MBOT) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened

Microbot Medical (NASDAQ:MBOT) Share Price Crosses Above Two Hundred Day Moving Average - What's Next...

$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab

Markets are heading into the close, with a series of high-impact corporate developments that are reshaping narratives across defense, biotech, cybersecurity, robotics, and enterprise software. Several small- and mid-cap names are flashing disconnects between fundamentals and valuation, in some cases dramatically so. NAPC Defense (OTCID:BLIS) announced $38M in new and recently finalized U.S. government task orders

Microbot Medical (NASDAQ:MBOT) Posts Earnings Results, Misses Expectations By $0.01 EPS

Microbot Medical (NASDAQ:MBOT - Get Free Report) released its quarterly earnings data on Wednesday. The biotechnology company reported ($0.07) earnings per share for the quarter, missing the...

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Microbot Medical Inc

iShares Dynamic Equity Active ETF ($BDYN)

Grayscale Bitcoin Trust ETF ($GBTC)

Destiny Tech100 Inc ($DXYZ)

Global X Defense Tech ETF ($SHLD)

The Modern Portfolio Builder. This award honors the fund that makes long-term investing easier, cheaper, or more effective for people who want to "set it and forget it."

MBOT
Microbot Medical Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MBOT News

MBOTMicrobot Medical Inc